EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo-Reference-Cited by-同舟云学术

EDL-291, a novel isoquinoline, presents antiglioblastoma effects in vitro and in vivo

Published:2012-06 Issue:5 Volume:23 Page:494-504
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Wang Xiang-Di,Freeman Natalie E.,Patil Renukadevi,Patil Shivaputra A.,Mitra Suchareeta,Orr William E.,Abner Clint W.,Yates Charles Ryan,Miller Duane D.,Geisert Eldon E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference39 articles.

1. Brain tumor survival: results from the National Cancer Data Base.;Surawicz;J Neurooncol,1998

2. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.;Laws;J Neurosurg,2003

3. Changing paradigms - an update on the multidisciplinary management of malignant glioma.;Stupp;Oncologist,2006

4. World Health Organization classification of tumors.;Kleihues;Cancer,2000

5. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis.;Lefranc;J Clin Oncol,2005

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tetrahydroisoquinolines in therapeutics: a patent review (2010-2015);Expert Opinion on Therapeutic Patents;2016-09-22

2. Untangling knots between autophagic targets and candidate drugs, in cancer therapy;Cell Proliferation;2015-02-04

3. Synthesis and In Vitro Evaluation of Novel 1,2,3,4-Tetrahydroisoquinoline Derivatives as Potent Antiglioma Agents;Anti-Cancer Agents in Medicinal Chemistry;2014-02

4. New substituted 4H-chromenes as anticancer agents;Bioorganic & Medicinal Chemistry Letters;2012-07